nfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginosa
Open Access
- 1 March 1995
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 39 (3) , 790-792
- https://doi.org/10.1128/aac.39.3.790
Abstract
Quinolone resistance gene nqr-T91 in a clinical isolate of Pseudomonas aeruginosa P1481 was cotransducible with catA1 in P. aeruginosa PAO. The nqr-T91 transductant, PKH-T91, was resistant to norfloxacin, imipenem, and chloramphenicol and showed less norfloxacin accumulation than the parent strain did. Loss of the 46-kDa outer membrane protein (D2) and an increase in the 50-kDa outer membrane protein in PKH-T91 were observed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Lipopolysaccharides in the transductant were also changed. These alterations were considered to be related to lower levels of norfloxacin accumulation in PKH-T91. These genetic and biochemical properties suggested that an nfxC type of quinolone-resistant mutation occurred in a clinical isolate of P. aeruginosa P1481.Keywords
This publication has 28 references indexed in Scilit:
- Prevalence of fluoroquinolone resistance in EuropeInfection, 1994
- Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after flooroqmnolone therapyJournal of Antimicrobial Chemotherapy, 1992
- Broad-host-range gyrase A gene probeAntimicrobial Agents and Chemotherapy, 1990
- Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1990
- Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reductionAntimicrobial Agents and Chemotherapy, 1989
- Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulationAntimicrobial Agents and Chemotherapy, 1989
- Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12Antimicrobial Agents and Chemotherapy, 1986
- ORAL CIPROFLOXACIN THERAPY OF INFECTIONS DUE TO PSEUDOMONAS AERUGINOSAThe Lancet, 1986
- Chromosomal locations ofcatA, pobA, pcaA, dcuandchugenes inPseudomonas aeruginosaGenetics Research, 1981
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970